Breast cancer. Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Intervention group of patients: 100 mg Q10 daily for 2 months. Intervention 2: Intervention group of non patients: 100 mg Q10 daily for 2 months. Intervention 3: Control group of pati
Treatment - Drugs
Intervention group of patients: 100 mg Q10 daily for 2 months
Intervention group of non patients: 100 mg Q10 daily for 2 months
Control group of patients: placebo for 2 months
Control group of non patients: placebo for 2 months
Sponsors
Vice Chancellor for research of Ahvaz University of Medical Sciences
Nutrition and Metabolic Disorders Research Center
Eligibility
Sex/Gender
Female
Age
19 Years to 49 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : diagnosed with positive estrogen receptor breast cancer by a physician; chemotherapy and radiation therapy, and a history of taking tamoxifen for at least a year; Not taking Q10 supplement and other antioxidants such as vitamin E; Willingness to comply with all interventions and follow-up procedures; Non-pregnant and non-lactating; Having no uncontrolled diseases such as diabetes and thyroid; Not taking non-prescription drugs, corticosteroids, statins Exclusion criteria : metastasis; partial or total mastectomy and not having any of the above entry criteria
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quten serum levels. Timepoint: Before intervention. Method of measurement: Pg/ml using biochemical kits.;Interluekin 6 serum levels. Timepoint: Before and after intervention. Method of measurement: Pg/ml using biochemical kits.;Interluekin 8 serum levels. Timepoint: Before and after intervention. Method of measurement: Pg/ml using biochemical kits.;VEGF serum levels. Timepoint: Before and after intervention. Method of measurement: Pg/ml using biochemical kits.;Quality of life. Timepoint: Before and after intervention. Method of measurement: Breast cancer Quality of Life Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Before and after intervention. Method of measurement: Scale.;Dietary intake. Timepoint: Before and after intervention. Method of measurement: Three-day record. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazanin Zahrooni
Paramedical Faculty
Outcome results
None listed